Remove Antibody Remove Gene Silencing Remove Genetics Remove Trials
article thumbnail

NICE backs NHS use of Novartis’ cholesterol drug Leqvio

pharmaphorum

As well as the access agreement for high-risk patients, the Novartis deal also covers a large-scale trial of the PCSK9 inhibitor and the creation of a consortium with academic groups aimed at improving the manufacturing of oligonucleotide drugs in the UK. This needs further thought,” he added.

Drugs 98
article thumbnail

2020 review – Pharma’s progress outside of COVID-19

pharmaphorum

The American Society of Clinical Oncology (ASCO) annual conference was one of the highlights of the year in cancer research and the fact it was held virtually did not distract from some stunning clinical lung cancer trial results presented by AstraZeneca. In the 500 patient trial, patients treated with Trodelvy lived for a median of 12.1

article thumbnail

Unfolding The Folds Of Transthyretin

Delveinsight

The hATTR diagnosis is mainly dependent on symptoms and can be confirmed via performing tissue biopsies, genetic testing, and imaging studies. Gene-silencing Therapies. Silencing or modifying gene TTR aims to reduce the effect of both variant and wild-type TTR gene, thus reducing hepatic production by targeting its mRNA.